Press releases

First system to selectively stimulate targeted areas of the brain to manage symptoms of debilitating disease

Patients In Germany receive new transcatheter aortic valve implantation devices specially designed for total control and accurate deployment.

Boston Scientific will participate in the healthcare conference on November 12 in Scottsdale, AZ. Learn how to watch the webcast or replay.

Advances Boston Scientific's ability to more comprehensively serve the rapidly expanding global EP market.

New data demonstrate successful deployment in all 120 patients with no severe paravalvular regurgitation at 30 days

Boston Scientific will participate in the healthcare conference on November 12. Learn how to watch the webcast or replay.

REDUCE-HTN data presented today at TCT demonstrate excellent safety profile.

Boston Scientific Corporation (NYSE: BSX) will highlight the strength of its advanced portfolio and plans for delivering additional meaningful...

Transcatheter Aortic Valve Replacement (TAVR) device offers precise positioning and placement, offering physicians unprecedented control.

Jeffrey Capello to transition out of CFO role at year-end

"We accelerated our operational performance in the quarter while enhancing our ability to deliver meaningful innovation,” said CEO Mike Mahoney.

Revolutionary procedure clinically proven to provide long term reduction of asthma exacerbations

Award recognizes innovative S-ICD® System, the world's first and only subcutaneous implantable defibrillator.

Boston Scientific will webcast its conference call with financial results and business highlights for Q3 ending September 30, 2013. Learn how to tune in.

MAJESTIC trial to study self-expanding DES System designed to treat superficial femoral artery (SFA) lesions.

University of Pittsburgh independent study of contemporary heart failure devices highlights industry-leading Boston Scientific battery longevity.

Re-ROUTE trial data presented at VIVA 2013 late-breaking session

Agreement settles all stent-related disputes between the companies.

Reinforcing company's ongoing commitment to leadership in the global medical technology market.

REPRISE II data honored as Best Abstract 2013 at PCR London valves course

Represents significant milestone toward obtaining additional key regulatory approvals for the SYNERGY™ Stent System.

Unlike medications alone, bronchial thermoplasty provides benefits that last for years rather than hours

Boston Scientific will participate in the healthcare conference on September 11 in Boston. Learn how to watch the webcast or replay.

Boston Scientific will participate in the healthcare conference on September 9 in New York. Learn how to watch the webcast or replay.

First implantations in Zhejiang province and Beijing mark the launch of the COGNIS CRT-D in the Chinese market.